MiRNA-based therapy for Human Cancer: MiRNA-1 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 29/September/2014, 5.13 am

Mechanism of tumor suppression: C/EBPα suppresses the expression of pro-proliferative protein Rab18/ WARBM3 via up regulation of its target gene, 28/September/2014, 06.09 am
September 28, 2014
Molecular therapy for Psoriasis: BMP4 decreases psoriasiform skin inflammation via down regulation of its target gene, 29/September/2014, 05.18 am
September 28, 2014
Show all

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study provides mechanistic insights into how TPP1 regulates telomerase function.

In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: MiRNA-based therapy for Human Cancer: MiRNA-1 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene.  Remarkably, over 90% human tumors over express telomerase, suggesting that inhibition of its activity may increase the efficacy of anticancer therapy.  Together, this study suggests that pharmacological formulations encompassing MiRNA-1 or its activators” can be used to treat human cancers.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  MiRNA-based therapy for Human Cancer: MiRNA-1 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 29/September/2014, 5.13 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.